I get your point, but only to a point. Yes, we should all be proud, but the number of shares one owns may have nothing to do with how long one has been invested. I have been here since early 2018 and have purchased at a low of $.33 (a piece of paper that I plan to frame one day soon) and high of $3.52 (last week). That being said, no, I don't own over 50,000 shares (wish I had bought more!), but however much I do own represents what I could spend, as well as my faith in the company, which, let's not forget, is still a company with ZERO products approved and ZERO income. Of course both of those things are about to change.
Picture the kid, just starting out collecting baseball cards, spending his $20 allowance on a card of his favorite player, but he only has about a dozen cards in his collection because financially, that is what he can afford. Is he less of a collector because some people can drop over $1 million on a 1909 T206 Honus Wagner or 1952 Topps Mickey Mantle? I don't think so.
Overall, I personally risked what I could over the past 2 years because I do believe in CYDY and have NEVER sold a single share, nor do I plan to for quite a while. I believe we'll see over $50/share next year, with the potential revenue in COVID alone for 2021 according to NP (I think about $9 billion give or take).
The price of CYDY is so low right now, and again, ANYTHING could go wrong (probably won't), so I applaud anyone risking their money now, no matter how much, until the day we have an approved product that is saving lives, no matter what the indication is. After approval, well, that's like jumping on the Yankees bandwagon in 1996 and not having been there for the lean 1982-1995 years.
Picture the kid, just starting out collecting baseball cards, spending his $20 allowance on a card of his favorite player, but he only has about a dozen cards in his collection because financially, that is what he can afford. Is he less of a collector because some people can drop over $1 million on a 1909 T206 Honus Wagner or 1952 Topps Mickey Mantle? I don't think so.
Overall, I personally risked what I could over the past 2 years because I do believe in CYDY and have NEVER sold a single share, nor do I plan to for quite a while. I believe we'll see over $50/share next year, with the potential revenue in COVID alone for 2021 according to NP (I think about $9 billion give or take).
The price of CYDY is so low right now, and again, ANYTHING could go wrong (probably won't), so I applaud anyone risking their money now, no matter how much, until the day we have an approved product that is saving lives, no matter what the indication is. After approval, well, that's like jumping on the Yankees bandwagon in 1996 and not having been there for the lean 1982-1995 years.
5
